Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:7 Issue:9 Number:23 ISSN#:2563-5476
RCT
ACE Report #10384
Ace Report Cover Cannabis

Vaporized cannabis improves pain in neuropathic pain disorders


How to Cite

OrthoEvidence. Vaporized cannabis improves pain in neuropathic pain disorders. ACE Report. 2018;7(9):23. Available from: https://myorthoevidene.com/AceReport/Report/10384

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Low-dose vaporized cannabis significantly improves neuropathic pain

J Pain. 2013 Feb;14(2):136-48. doi: 10.1016/j.jpain.2012.10.009

Contributing Authors: B Wilsey T Marcotte R Deutsch B Gouaux S Sakai H Donaghe

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

39 adults with neuropathic pain conditions received low-dose vaporized cannabis, medium-dose vaporized cannabis and placebo in a random order. The primary outcome was pain intensity and secondary outcomes included the patient impression of global change, a neuropathic pain scale, allodynia, heat-pain threshold, and mood. Low and moderate-dose vaporized cannabis reduced pain intensity and most adve...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE